Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

356 METHOTREXATE
Eccrine squamous syringometaplasia
(1997): Valks R+, Arch Dermatol 133, 873
Edema
(2003): Prescrire Int 12(64), 59
Erosion of psoriatic plaques
(2003): Kazlow DW+, JAmAcadDermatol49, S197
(1996): Pearce HP+, JAmAcadDermatol35, 835
(1988): Kaplan DL+, Int J Dermatol 27, 59
(1988): Shupack JL+, JAMA 259, 3594
(1987): Ng HW+, BMJ 295, 752
(1984): Lawrence CM+, JAmAcadDermatol11, 1059
(1983): Reed KM+, JAmAcadDermatol8, 677
Erosions
(1996): Zackheim HS+, JAmAcadDermatol34, 626
Erythema (>10%)
Erythema multiforme
(1999): Goerttler E+, JAmAcadDermatol40, 702 (4 cases)
(1989): Taylor SW+, Gynecol Oncol 33, 376
Erythroderma
(2000): Alfaro J+, Rev Med Chil (Spanish) 128, 315
(1996): Zackheim HS+, JAmAcadDermatol34, 626
Exanthems (15%)
(2003): Feizy V+, Dermatol Online J 9(1), 14
Folliculitis
Furunculosis
(1996): Zackheim HS+, JAmAcadDermatol34, 626
Herpes simplex
(1996): Vonderheid EC+, JAmAcadDermatol34, 470
Herpes zoster
(2005): Kinder AJ+, Rheumatology (Oxford) 44(1), 61
Inflammation (reactivation)
Lymphadenopathy
(2006): Svensson AM+, Int J Hematol 83(1), 47
Lymphoma
(2006): Chim CS+, Haematologica 91(8), ECR3
(2006): Ikeda J+, Int J Hematol 83(4), 363
(2006): Kennedy JW+, JHandSurg[AM]31(7), 1193
(2006): Kojima M+, Pathol Res Pract 202(9), 679
Melanoma
(1984): Wemmer U, ZHautkr(German) 59, 665
Molluscum contagiosum
(2007): Lim KS+, Clin Exp Dermatol 32(5), 591
Necrosis
(1987): Harrison PV, Br J Dermatol 116, 867
(1983): Reed KM+, JAmAcadDermatol8, 677
(1982): Lawrence CM+, Br J Dermatol 107, 24
Nodular eruption
(2004): Rivero MG+, Rheumatology (Oxford) 43(12), 1587
(2001): Ahmed SS+, Medicine (Baltimore) 80(4), 271
(1999): Dash S+, J Rheumatol 26(6), 1396
(1999): Jang KA+, JDermatol26(7), 460
(1998): Williams FM+, JAmAcadDermatol39, 359
(1997): Falcini F+, Arthritis Rheum 40(1), 175
(1996): Muzaffer MA+, JPediatr128, 698
(1996): Smith MD, J Rheumatol 23, 2004
(1995): Berris B+, J Rheumatol 22, 2359
(1995): Das SK+, J Assoc Physicians India 43, 651
(1994): Abu-Shakra M+, J Rheumatol 21, 934
(1994): Karam NE+, J Rheumatol 21, 1960
(1994): Smith MD, J Rheumatol 22, 1439
(1992): Kerstens PJSM+, J Rheumatol 19, 867
(1988): Segal R+, Arthritis Rheum 31, 1182
Non-Hodgkin’s lymphoma
(2006): Acero J+, J Oral Maxillofac Surg 64(4), 708
(2006): Mackie GC+, Clin Nucl Med 31(5), 272
Photo-recall
(2002): Thami GP+, Postgrad Med J 78(916), 116
(2001): Camidge DR, Am J Clin Oncol 24(2), 211
(2000): Kharfan Dabaja MA+, Am J Clin Oncol 23(5), 531
(1995): Guzzo C+, Photodermatol Photoimmunol Photomed
11, 55 (sunburn)
Photosensitivity (5%)
(2002): Thami GP+, Postgrad Med J 78(916), 116 (recall)
(1996): Zackheim HS+, JAmAcadDermatol34, 626
(1994): Oliver F, The Schoch Letter 44, 6 (observation)
(1985): Neiman RA+, J Rheumatol 12, 354
Pigmentation (1–10%)
Pruritus (1–5%)
(1998): Roenigk HH+, JAmAcadDermatol38, 478
Purpura
Radiodermatitis (reactivation)
Rash (sic) (1–3%)
(2000): Emery P+, Rheumatology (Oxford) 39(6), 655
(1995): Copur S+, Anticancer Drugs 6, 154
Raynaud’s phenomenon
(1988): Segal R+, Arthritis Rheum 31(9), 1182
Scabies (reactivation)
Side effects (sic)
(1997): Kasteler JS+, JAmAcadDermatol36, 67 (passim)
(1996): Furuya T+, Rymachi (Japanese) 36, 746
Squamous cell carcinoma
(1989): Jensen DB+, Acta Derm Venereol (Stockh) 69, 274
Stevens–Johnson syndrome
(2000): Hani N+, Eur J Dermatol 10(7), 548
(1993): Cuthbert RJ+, Ulster Med J 62, 95
Sunburn (reactivation)
(2000): Khan AJ+, Cutis 66, 379
(1998): Roenigk HH+, JAmAcadDermatol38, 478
(1987): Westwick TJ+, Cutis 39, 49
(1986): Mallory SB+, Pediatrics 78, 514
(1981): Korossy KS+, Arch Dermatol 117, 310
Telangiectasia
Toxic epidermal necrolysis (10%)
(2000): Borcea A+, Br J Dermatol 143, 203 (urticarial)
(1998): Halevy S+, J Eur Acad Dermatol Venereol 10, 81
(1997): Torner O+, Clin Rheumatol 16, 108
(1995): Blanco R+, Arthritis Rheum 39, 1016
(1989): Fondevila CG+, Br J Haematol 72, 591
(1989): Jeurissen MEC+, Clin Rheumatol 8, 417
(1988): Segal R+, Arthritis Rheum 31(9), 1182
(1986): Navarro M+, AnnInternMed105, 471
(1984): Marks CR+, AnnInternMed100, 916